Open

Developing treatments for type 1 diabetes

We are studying different types of treatments that modify the activity of immune cells involved in type 1 diabetes, also known as autoimmune diabetes.

Age & Gender

7 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

During the visit you will meet with a member of the study team, fill out a short questionnaire, and have a a single blood draw taken.

Incentives

$35

In-person visits:
One

Total length of participation:
Participation time entails the amount of time required to obtain a blood draw, which is generally less than 1 hour.

Looking for Specific Volunteers

Able to participate:

type 1 diabetes

Not eligible if:

None

Looking for Healthy Volunteers

Requirements for healthy volunteers are different than for those with a specific condition. If you are interested in becoming a healthy volunteer for this study, use the below categories to determine if you are able to participate.

Able to participate:

Healthy individual

Not eligible if:

None

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Roland Tisch
Microbiology and Immunology

Study Type

Clinical or Medical
Interventional

Study Topics

Diabetes
Healthy Volunteer or General Population

IRB Number

14-0749

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.